| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $1,415,413 ) |
| | 2025 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01MH074090 | Gene Dosage Imbalance in Neurodevelopmental Disorders | 000 | 19 | NIH | 12/3/2024 | $675,215 |
| | 2025 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H7646012 | Ryan White Part C Outpatient EIS Program | 00 | 4 | HRSA | 4/28/2025 | $87,477 |
| | 2025 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R33HL161775 | Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH | 001 | 4 | NIH | 3/17/2025 | $654,444 |
| | 2025 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | NU58DP007587 | The Innovative Cardiovascular Health Program | 01 | 2 | CDC | 5/5/2025 | $0 |
| | 2025 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H79TI084778 | Free2BMom | 000 | 3 | SAMHSA | 12/10/2024 | $0 |
| | 2025 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL148246 | Identification Methods, Patient Activation, and Cascade Testing for FH: IMPACT-FH | 001 | 5 | NIH | 4/3/2025 | $124,574 |
| | 2025 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R33HL161775 | Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH | 000 | 3 | NIH | 11/28/2024 | $0 |
| | 2025 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R61DA059880 | Evaluation of a peer recovery support program adapted to target retention in clinic-based medication for opioid use disorder treatment | 000 | 1 | NIH | 12/20/2024 | $0 |
| | 2025 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01MH119705 | Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders | 000 | 5 | NIH | 4/29/2025 | $0 |
| | 2025 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01MH119705 | Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders | 000 | 5 | NIH | 4/29/2025 | $0 |
| | 2025 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01MH119705 | Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders | 000 | 5 | NIH | 4/29/2025 | $0 |
| | 2025 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL141901 | A Precision Medicine Approach to Arrhythmogenic Cardiomyopathy | 000 | 5 | NIH | 4/29/2025 | $0 |
| | 2025 | 2022 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HG009671 | Reporting Adult-Onset Genomic Results to Pediatric Biobank Participants and Parents | 000 | 5 | NIH | 11/1/2024 | -$1,723 |
| | 2025 | 2022 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL148246 | Identification Methods, Patient Activation, and Cascade Testing for FH: IMPACT-FH | 000 | 4 | NIH | 4/3/2025 | -$124,574 |
|
| Issue Date FY: 2024 ( Subtotal = $12,030,848 ) (Continued on the next page) |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01MH074090 | Gene Dosage Imbalance in Neurodevelopmental Disorders | 001 | 18 | NIH | 7/5/2024 | $79,283 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R33HL161775 | Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH | 001 | 3 | NIH | 2/24/2024 | $658,852 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL172022 | Blood Trauma, Vascular Remodeling, and Vasoregulation with Total Body Continuous Versus Pulsatile Artificial Circulation | 000 | 1 | NIH | 8/9/2024 | $676,970 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | T6249313 | Integrated Substance Use Disorder (SUD) Training Program | 01 | 2 | HRSA | 7/10/2024 | $33,928 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | T6249313 | Integrated Substance Use Disorder (SUD) Training Program | 00 | 2 | HRSA | 5/8/2024 | $514,392 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | T2537597 | Addiction Medicine Fellowship | 00 | 5 | HRSA | 5/16/2024 | $541,657 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | D5837570 | Residency Training in Primary Care | 00 | 5 | HRSA | 5/9/2024 | $499,906 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | D5837570 | Residency Training in Primary Care | 01 | 5 | HRSA | 7/9/2024 | $0 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | T2537597 | Addiction Medicine Fellowship | 01 | 5 | HRSA | 7/23/2024 | $24,612 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U18DP006509 | DP20-001 Electronic Health Record-based Surveillance of Diabetes by Type in Young Adults in Pennsylvania | 00 | 5 | CDC | 6/7/2024 | $54,005 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U18DP006509 | DP20-001 Electronic Health Record-based Surveillance of Diabetes by Type in Young Adults in Pennsylvania | 00 | 5 | CDC | 6/7/2024 | $195,995 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H79TI084778 | Free2BMom | 003 | 3 | SAMHSA | 6/15/2024 | $520,104 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01HL146188 | Collaborative Research to Explore Genetic Variation and Phenotypic Spectrum of Elastin and Related Genes | 002 | 5 | NIH | 6/21/2024 | $50,281 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01HL146188 | Collaborative Research to Explore Genetic Variation and Phenotypic Spectrum of Elastin and Related Genes | 001 | 5 | NIH | 5/8/2024 | $0 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01HL146188 | Collaborative Research to Explore Genetic Variation and Phenotypic Spectrum of Elastin and Related Genes | 000 | 5 | NIH | 2/27/2024 | $565,660 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01HL146188 | Collaborative Research to Explore Genetic Variation and Phenotypic Spectrum of Elastin and Related Genes | 003 | 5 | NIH | 9/7/2024 | $0 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL159182 | Improving Risk Stratification in Familial Hypercholesterolemia (RISK-FH) | 000 | 3 | NIH | 7/31/2024 | $724,211 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL148246 | Identification Methods, Patient Activation, and Cascade Testing for FH: IMPACT-FH | 003 | 5 | NIH | 8/30/2024 | $0 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL148246 | Identification Methods, Patient Activation, and Cascade Testing for FH: IMPACT-FH | 002 | 5 | NIH | 6/21/2024 | $78,097 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL148246 | Identification Methods, Patient Activation, and Cascade Testing for FH: IMPACT-FH | 000 | 5 | NIH | 1/30/2024 | $718,610 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | K01DA049903 | Understanding the role of community determinants in opioid use disorder and program implementation factors influencing patient adherence to opioid agonist therapy | 000 | 5 | NIH | 5/24/2024 | $162,032 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01MH137191 | 7/7-PsycheMERGE: Advancing Precision Psychiatry | 000 | 1 | NIH | 9/16/2024 | $812,950 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | NU58DP007587 | The Innovative Cardiovascular Health Program | 00 | 2 | CDC | 6/28/2024 | $650,000 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01HG013796 | Making Genomic Medicine Routine in a Rural Healthcare System | 000 | 1 | NIH | 9/23/2024 | $478,240 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01HG013796 | Making Genomic Medicine Routine in a Rural Healthcare System | 000 | 1 | NIH | 9/23/2024 | $193,818 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HG011799 | Real-time genetic diagnosis at the point of care | 000 | 4 | NIH | 7/18/2024 | $902,661 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H7646012 | Ryan White Part C Outpatient EIS Program | 02 | 3 | HRSA | 8/1/2024 | $5,000 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H7646012 | Ryan White Part C Outpatient EIS Program | 01 | 3 | HRSA | 5/31/2024 | $262,495 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | H7646012 | Ryan White Part C Outpatient EIS Program | 00 | 3 | HRSA | 3/6/2024 | $87,498 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HD104938 | Characterizing the spectrum of genomic and phenotypic variation in cerebral palsy | 001 | 3 | NIH | 7/15/2024 | $666,187 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL148246 | Identification Methods, Patient Activation, and Cascade Testing for FH: IMPACT-FH | 001 | 5 | NIH | 3/8/2024 | $0 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | UG1CA189847 | Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP) | 000 | 11 | NIH | 7/25/2024 | $1,491,429 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R33HL161775 | Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH | 002 | 3 | NIH | 6/21/2024 | $58,564 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01MH074090 | Gene Dosage Imbalance in Neurodevelopmental Disorders | 000 | 18 | NIH | 1/5/2024 | $713,564 |
|
